MENU

LTRN Lantern Pharma Forecast, Technical & Fundamental Analysis

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published Earnings

LTRN is expected to report earnings to fall 22.81% to -43 cents per share on March 11

Lantern Pharma LTRN Stock Earnings Reports
Q4'26
Est.
$-0.44
Q2'26
Missed
by $0.19
Q4'25
Beat
by $0.18
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.13
The last earnings report on August 14 showed earnings per share of -56 cents, missing the estimate of -37 cents. With 86.80K shares outstanding, the current market capitalization sits at 7.26M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NI45.290.23
+0.51%
NiSource
SBCF34.07-0.05
-0.15%
Seacoast Banking Corp
CVGI3.21-0.01
-0.31%
Commercial Vehicle Group
AESI5.36-0.18
-3.25%
Atlas Energy Solutions
CHSN2.35-0.36
-13.28%
Chanson International Holding

LTRN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with ALZN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
-22.70%
ALZN - LTRN
38%
Loosely correlated
-5.92%
WHWK - LTRN
36%
Loosely correlated
-4.35%
AXON - LTRN
36%
Loosely correlated
-0.21%
CGTX - LTRN
34%
Loosely correlated
-2.95%
CCCC - LTRN
33%
Loosely correlated
-4.76%
More
A.I. Advisor
published General Information

General Information

a company, which engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data

Industry Biotechnology

Industry
N/A
Address
1920 McKinney Avenue
Phone
+1 972 277-1136
Employees
16
Web
https://www.lanternpharma.com